|
1
|
Pierce JG and Parsons TF: Glycoprotein
hormones: Structure and function. Annu Rev Biochem. 50:465–495.
1981. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cole LA: hCG, five independent molecules.
Clin Chim Acta. 413:48–65. 2012. View Article : Google Scholar
|
|
3
|
Iles RK and Butler SA: Gonadotropins and
gonadotropin receptors - evolutional genetics, signalling
mechanisms, extra gonadal function and roles in oncogenesis. Mol
Cell Endocrinol. 329:1–2. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iles RK, Delves PJ and Butler SA: Does hCG
or hCGβ play a role in cancer cell biology? Mol Cell Endocrinol.
329:62–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsampalas M, Gridelet V, Berndt S, Foidart
JM, Geenen V and Perrier d'Hauterive S: Human chorionic
gonadotropin: A hormone with immunological and angiogenic
properties. J Reprod Immunol. 85:93–98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zygmunt M, Herr F, Keller-Schoenwetter S,
Kunzi-Rapp K, Münstedt K, Rao CV, Lang U and Preissner KT:
Characterization of human chorionic gonadotropin as a novel
angiogenic factor. J Clin Endocrinol Metab. 87:5290–5296. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burczynska BB, Kobrouly L, Butler SA,
Naase M and Iles RK: Novel insights into the expression of CGB1 and
2 genes by epithelial cancer cell lines secreting ectopic free
hCGβ. Anticancer Res. 34:2239–2248. 2014.PubMed/NCBI
|
|
8
|
Lee CL, Chiu PC, Hautala L, Salo T, Yeung
WS, Stenman UH and Koistinen H: Human chorionic gonadotropin and
its free β-subunit stimulate trophoblast invasion independent of
LH/hCG receptor. Mol Cell Endocrinol. 375:43–52. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Butler SA and Iles RK: The free monomeric
beta subunit of human chorionic gonadotrophin (hCG beta) and the
recently identified homodimeric beta-beta subunit (hCG beta beta)
both have autocrine growth effects. Tumour Biol. 25:18–23. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prast J, Saleh L, Husslein H, Sonderegger
S, Helmer H and Knöfler M: Human chorionic gonadotropin stimulates
trophoblast invasion through extracellularly regulated kinase and
AKT signaling. Endocrinology. 149:979–987. 2008. View Article : Google Scholar
|
|
11
|
Hamada AL, Nakabayashi K, Sato A, Kiyoshi
K, Takamatsu Y, Laoag-Fernandez JB, Ohara N and Maruo T:
Transfection of antisense chorionic gonadotropin β gene into
choriocarcinoma cells suppresses the cell proliferation and induces
apoptosis. J Clin Endocrinol Metab. 90:4873–4879. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jankowska A, Gunderson SI, Andrusiewicz M,
Burczynska B, Szczerba A, Jarmolowski A, Nowak-Markwitz E and
Warchol JB: Reduction of human chorionic gonadotropin beta subunit
expression by modified U1 snRNA caused apoptosis in cervical cancer
cells. Mol Cancer. 7:26–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo X, Liu G, Schauer IG, Yang G,
Mercado-Uribe I, Yang F, Zhang S, He Y and Liu J: Overexpression of
the β subunit of human chorionic gonadotropin promotes the
transformation of human ovarian epithelial cells and ovarian
tumorigenesis. Am J Pathol. 179:1385–1393. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li D, Wen X, Ghali L, Al-Shalabi FM,
Docherty SM, Purkis P and Iles RK: hCG beta expression by cervical
squamous carcinoma - in vivo histological association with tumour
invasion and apoptosis. Histopathology. 53:147–155. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mandai M, Konishi I, Kuroda H and Fujii S:
LH/hCG action and development of ovarian cancer - a short review on
biological and clinical/epidemiological aspects. Mol Cell
Endocrinol. 269:61–64. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Głodek A and Jankowska A: CGB activates
ERK and AKT kinases in cancer cells via LHCGR-independent
mechanism. Tumour Biol. 35:5467–5479. 2014. View Article : Google Scholar
|
|
17
|
Hotakainen K, Lintula S, Jarvinen R, Paju
A, Stenman J, Rintala E and Stenman UH: Overexpression of human
chorionic gonadotropin beta genes 3, 5 and 8 in tumor tissue and
urinary cells of bladder cancer patients. Tumour Biol. 28:52–56.
2007. View Article : Google Scholar
|
|
18
|
Iles RK: Ectopic hCGbeta expression by
epithelial cancer: Malignant behaviour, metastasis and inhibition
of tumor cell apoptosis. Mol Cell Endocrinol. 260–262:264–270.
2007. View Article : Google Scholar
|
|
19
|
Philchenkov A: Caspases: Potential targets
for regulating cell death. J Cell Mol Med. 8:432–444. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kurman RJ: Origin and molecular
pathogenesis of ovarian high-grade serous carcinoma. Ann oncol.
24(Suppl 10): x16–21. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kubiczak M, Walkowiak GP, Nowak-Markwitz E
and Jankowska A: Human chorionic gonadotropin beta subunit genes
CGB1 and CGB2 are transcriptionally active in ovarian cancer. Int J
Mol Sci. 14:12650–12660. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: Release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yin C, Knudson CM, Korsmeyer SJ and van
Dyke T: Bax suppresses tumorigenesis and stimulates apoptosis in
vivo. Nature. 385:637–640. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sugino N, Suzuki T, Kashida S, Karube A,
Takiguchi S and Kato H: Expression of Bcl-2 and Bax in the human
corpus luteum during the menstrual cycle and in early pregnancy:
Regulation by human chorionic gonadotropin. J Clin Endocrinol
Metab. 85:4379–4386. 2000.PubMed/NCBI
|
|
25
|
Basu A and Haldar S: The relationship
between Bci2, Bax and p53: Consequences for cell cycle progression
and cell death. Mol Hum Reprod. 4:1099–1109. 1998. View Article : Google Scholar
|
|
26
|
Yoon O and Roh J: Downregulation of KLF4
and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer.
Oncol Lett. 4:1033–1036. 2012.PubMed/NCBI
|
|
27
|
Waligórska-Stachura J, Jankowska A, Waśko
R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-Błaszyk D, Shimek
V and Ruchała M: Survivin - prognostic tumor biomarker in human
neoplasms - review. Ginekol Pol. 83:537–540. 2012.
|
|
28
|
Kumazawa Y, Kawamura K, Sato T, Sato N,
Konishi Y, Shimizu Y, Fukuda J, Kodama H and Tanaka T: HCG
up-regulates survivin mRNA in human granulosa cells. Mol Hum
Reprod. 11:161–166. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hoffman YM, Peegel H, Sprock MJ, Zhang QY
and Menon KM: Evidence that human chorionic
gonadotropin/luteinizing hormone receptor down-regulation involves
decreased levels of receptor messenger ribonucleic acid.
Endocrinology. 128:388–393. 1991. View Article : Google Scholar : PubMed/NCBI
|
